Somatostatin Receptor Knockout Mice and Huntington's Disease
Author Information
Author(s): Rajput Padmesh S., Kharmate Geetanjali, Norman Michael, Liu Shi-He, Sastry Bhagavatula R., Brunicardi Charles F., Kumar Ujendra
Primary Institution: The University of British Columbia
Hypothesis
The study investigates the role of somatostatin receptors in neurodegeneration and their potential involvement in Huntington's disease pathology.
Conclusion
The study suggests that somatostatin and its receptors may play a significant role in regulating neurodegeneration, providing insights into Huntington's disease.
Supporting Evidence
- The study found significant loss of DARPP-32 in both SSTR1/5 knockout and R6/2 mice.
- Calbindin expression was increased in both SSTR1/5 knockout and R6/2 mice compared to wild-type.
- SSTR1/5 knockout mice exhibited neurochemical changes similar to those seen in Huntington's disease models.
- Activation of NMDA receptors was linked to neurodegeneration in both mouse models.
- Somatostatin and its receptors may have neuroprotective roles in the context of Huntington's disease.
Takeaway
Researchers looked at mice without certain brain receptors to see how it affects brain health, especially in a disease like Huntington's.
Methodology
The study involved comparing the brain changes in SSTR1/5 knockout mice with those in Huntington's disease transgenic mice using various biochemical and immunohistochemical techniques.
Potential Biases
Potential bias in interpreting results due to the specific focus on somatostatin receptors without considering other neuroprotective factors.
Limitations
The study primarily focuses on specific receptor knockouts and may not account for other compensatory mechanisms in the brain.
Participant Demographics
Mice used in the study included both wild-type and genetically modified strains.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website